Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Its lead drug ersodetug, a monoclonal antibody, had earned two FDA Breakthrough Therapy Designations and the agency had signaled that its Phase 3 trial could support a BLA filing. In drug development today, therapies originally designed for one disease are being reimagined for broader use
B12 injections are clinically indicated for patients with confirmed deficiency or malabsorption conditions, including those with pernicious anaemia, gastrectomy, ileal resection, Crohn's disease, or neurological symptoms related to B12 deficiency
Nickel tested
Structural and functional diversity among agonist-bound states of the GLP-1 receptor
Are There Any Side Effects or Risks
